ÂÜÀòÂÒÂ×

Charles E. Hinkle, CFO of Zylö Therapeutics, began his career at Bain & Company and Bain Capital. He was then CEO and CFO of an automotive foundry from 1985 to 2015, where he led this manufacturer’s growth from $4M to $50M in sales. During these years he built a greenfield plant in Monterrey MX and grew the startup Mexican operation into a significant portion of the company’s sales and operations. In 2015 he sold the foundries to a private equity firm for a $25 million enterprise value so that the company could gain access to additional capital for meeting customer growth plans. He then took over as CEO and CFO of a distressed oilfield equipment manufacturer and helped them avoid Chapter 11 in 2016 before working to diversify its product offerings as a basis for future growth. One diversification initiative was a startup company that developed and introduced a breakthrough technology in oilfield pipe handling. The startup was awarded 21 U.S. patents in 2020 and earned 43% EBITDA/sales profitability in 2019-2020.

Mr. Hinkle graduated summa cum laude from Washington and Lee University with a B.S. in accounting, earned his CPA certification from the State of Texas, and graduated as a Baker Scholar from Harvard Business School.